The Pediatric Blood Culture Bottle market is further categorized by Types, primarily differentiated by microbial detection capabilities. Aerobic bottles, designed to culture organisms requiring oxygen, constitute 50โ55% of the market share. Anaerobic bottles, targeting non-oxygen-dependent pathogens, account for 30โ35%. Specialized bottles, such as those for fungal or fastidious organisms, represent 15โ20%, driven by niche diagnostic needs. This market taxonomy underscores the role of technological differentiation in addressing pediatric-specific infections. Aerobic and anaerobic bottles remain the backbone of the market, while specialized variants are gaining traction in advanced healthcare ecosystems.